{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:35:26Z","timestamp":1776206126498,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02710-6","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T10:02:42Z","timestamp":1692784962000},"page":"2773-2774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Weight gain secondary to the use of Janus kinase inhibitors"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-0279","authenticated-orcid":false,"given":"Peter Yi","family":"Ch\u2019en","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9735-0100","authenticated-orcid":false,"given":"Eingun James","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"issue":"4","key":"2710_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","volume":"76","author":"W Damsky","year":"2017","unstructured":"Damsky W, King BA (2017) JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol 76(4):736\u2013744","journal-title":"J Am Acad Dermatol"},{"key":"2710_CR2","unstructured":"RINVOQ: Highlights of Prescribing Information. 2022."},{"key":"2710_CR3","unstructured":"A study of baricitinib (LY3009104) in participants with severe or very severe alopecia areata (BRAVE-AA1). ClinicalTrials.gov identifier: NCT03570749. 2022."},{"key":"2710_CR4","unstructured":"A study of baricitinib (LY3009104) in adults with severe or very severe alopecia areata (BRAVE-AA2). ClinicalTrials.gov identifier: NCT03899259. 2022. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03899259."},{"key":"2710_CR5","unstructured":"Unpublished internal company data - Eli Lilly and Company. 2022."},{"issue":"13","key":"2710_CR6","first-page":"1062","volume":"135","author":"N Moll\u00e9","year":"2020","unstructured":"Moll\u00e9 N, Krichevsky S, Kermani P, Silver RT, Ritchie E, Scandura JM (2020) Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2\/STAT3. Blood 135(13):1062\u20131066","journal-title":"Blood"},{"issue":"1","key":"2710_CR7","doi-asserted-by":"publisher","first-page":"16609","DOI":"10.1038\/s41598-019-53056-x","volume":"9","author":"M Sapre","year":"2019","unstructured":"Sapre M, Tremblay D, Wilck E, James A, Leiter A, Coltoff A et al (2019) Metabolic effects of JAK1\/2 inhibition in patients with myeloproliferative neoplasms. Sci Rep 9(1):16609","journal-title":"Sci Rep"},{"issue":"10","key":"2710_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.clml.2020.05.019","volume":"20","author":"A Coltoff","year":"2020","unstructured":"Coltoff A, Mesa R, Gotlib J, Shulman J, Rampal RK, Siwoski O et al (2020) Real-world outcomes of ruxolitinib treatment for polycythemia vera. Clin Lymphoma Myeloma Leuk 20(10):697-703.e1","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2710_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/2040620717693972","volume":"8","author":"S Alimam","year":"2017","unstructured":"Alimam S, Claire H (2017) Experience with ruxolitinib in the treatment of polycythaemia vera. Ther Adv Hematol 8(4):139\u2013151","journal-title":"Ther Adv Hematol"},{"issue":"6","key":"2710_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12656","volume":"31","author":"CC Yang","year":"2018","unstructured":"Yang CC, Khanna T, Sallee B, Christiano AM, Bordone LA (2018) Tofacitinib for the treatment of lichen planopilaris: a case series. Dermatol Ther 31(6):e12656","journal-title":"Dermatol Ther"},{"issue":"7","key":"2710_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00296-019-04303-x","volume":"39","author":"DS Novikova","year":"2019","unstructured":"Novikova DS, Udachkina HV, Markelova EI, Kirillova IG, Misiyuk AS, Demidova NV et al (2019) Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib. Rheumatol Int 39(7):1181\u20131189","journal-title":"Rheumatol Int"},{"issue":"4","key":"2710_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","volume":"77","author":"LY Liu","year":"2017","unstructured":"Liu LY, Strassner JP, Refat MA, Harris JE, King BA (2017) Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. J Am Acad Dermatol 77(4):675\u201382.e1","journal-title":"J Am Acad Dermatol"},{"issue":"34","key":"2710_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2152\/jmi.65.166","volume":"65","author":"M Chikugo","year":"2018","unstructured":"Chikugo M, Sebe M, Tsutsumi R, Iuchi M, Kishi J, Kuroda M et al (2018) Effect of Janus kinase inhibition by tofacitinib on body composition and glucose metabolism. J Med Invest 65(34):166\u2013170","journal-title":"J Med Invest"},{"key":"2710_CR14","unstructured":"Wollenhaupt J, Morel J, Daien C, Ruyssen-Witrand A, Lukas C, Richez C, Shapiro A, Chapman D, Cros M, Rivas J, Citera G (2020) Analysis of the impact of tofacitinib treatment on weight in patients with rheumatoid arthritis. Arthritis Rheumatol 72 (suppl 10). https:\/\/acrabstracts.org\/abstract\/analysis-of-the-impact-of-tofacitinibtreatment-on-weight-in-patients-with-rheumatoid-arthritis\/. Accessed 22 Aug 2023"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02710-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:03:28Z","timestamp":1698649408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":14,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2710"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02710-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no\u00a0\u00a0conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Exempt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}]}}